-
US begins testing mixed COVID-19 vaccine regimens
europeanpharmaceuticalreview
June 04, 2021
A Phase I/II trial will enrol 150 individuals already vaccinated against COVID-19 with one vaccine and assess the safety and immunogenicity of a booster dose of a different COVID-19 vaccine.
-
UK approves Janssen COVID-19 Vaccine
europeanpharmaceuticalreview
June 03, 2021
The Janssen COVID-19 Vaccine has been granted conditional marketing authorisation for use in people aged 18 and over in the UK.
-
EMA recommends first COVID-19 vaccine for children aged 12 to 15
europeanpharmaceuticalreview
June 03, 2021
The EMA is recommending that the Comirnaty® COVID-19 vaccine’s indication be extended to include children aged 12 to 15 years.
-
WHO authorises Sinovac’s COVID-19 vaccine for emergency use
pharmatimes
June 03, 2021
The World Health Organization (WHO) has validated Sinvoc’s COVID-19 vaccine for emergency use in adults aged 18 years and older in a two-dose schedule with a spacing of two to four weeks.
-
Cipla seeks clarity, guidance from Govt for import of COVID-19 vaccine
expresspharma
June 03, 2021
The company is seeking fast-track approvals to expeditiously bring Moderna's single-dose COVID-19 booster vaccine into India.
-
Biological E to produce Providence Therapeutics’ mRNA COVID-19 vaccine in India
expresspharma
June 03, 2021
Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latter’s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India.
-
University of Bradford to host COVID-19 vaccine booster trial
pharmatimes
June 02, 2021
The University of Bradford has announced that it will host COVID-19 vaccine booster trials at its Digital Health Enterprise Zone.
-
Sinovac COVID-19 vaccine gets WHO validation for emergency use
expresspharma
June 02, 2021
WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement.
-
ipla seeks clarity, guidance from Govt for import of COVID-19 vaccine
expresspharma
June 02, 2021
The company is seeking fast-track approvals to expeditiously bring Moderna's single-dose COVID-19 booster vaccine into India.
-
UK approves J&J’s one-dose COVID-19 vaccine
pharmatimes
June 01, 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine.